Home> Products> lupus patients

{ "products": [ { "_id": "6666d147899bdd18a04433c2", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "HYDROQUIZ 400 ", "description": "HYDROQUIZ 400 \nHydroxychloroquine (400mg)\nIntroduction\nHYDROQUIZ 400 contains Hydroxychloroquine (400mg), a versatile medication primarily used to treat autoimmune diseases such as rheumatoid arthritis and lupus erythematosus. It is also effective in the prevention and treatment of malaria. Hydroxychloroquine works by modulating the immune system and reducing inflammation, thereby alleviating symptoms and enhancing the quality of life for patients.\n\nKey Ingredient and Its Benefits\nHydroxychloroquine (400mg)\nImmunomodulatory Effects: Hydroxychloroquine helps modulate the immune system, reducing autoimmune reactions and inflammation, making it effective in treating conditions like rheumatoid arthritis and lupus.\nAnti-Inflammatory Properties: It helps reduce inflammation, alleviating symptoms such as joint pain, swelling, and stiffness in patients with rheumatoid arthritis.\nAntimalarial Action: Hydroxychloroquine is effective in both the prevention and treatment of malaria caused by Plasmodium falciparum. It interferes with the parasite's growth in red blood cells.\nSkin Health: It is used to treat skin manifestations associated with lupus erythematosus, helping to reduce rashes and lesions.\nBenefits of HYDROQUIZ 400\nManagement of Rheumatoid Arthritis: HYDROQUIZ 400 helps manage rheumatoid arthritis symptoms by reducing inflammation and joint damage, improving mobility and overall quality of life.\nTreatment of Lupus Erythematosus: The immunomodulatory effects of Hydroxychloroquine make it effective in treating lupus, reducing symptoms like skin rashes, joint pain, and fatigue.\nMalaria Prevention and Treatment: Hydroxychloroquine is a valuable medication for preventing and treating malaria, especially for travelers to malaria-endemic regions.\nEnhanced Skin Health: For lupus patients, HYDROQUIZ 400 helps reduce skin rashes and lesions, promoting healthier skin.\nLong-Term Safety: Hydroxychloroquine has a favorable safety profile for long-term use, making it suitable for managing chronic conditions.\nDosage and Administration\nDosage\nRheumatoid Arthritis and Lupus: The typical dosage for autoimmune conditions is one tablet (400mg) taken once daily, or as prescribed by a healthcare provider. Dosage may be adjusted based on the patient's response and specific needs.\nMalaria Prevention: For malaria prevention, the usual dosage is one tablet (400mg) taken once weekly, starting one to two weeks before entering a malaria-endemic area and continuing for four weeks after leaving the area.\nMalaria Treatment: For treating malaria, the initial and follow-up doses are determined by a healthcare provider based on the specific case.\nAdministration\nOral Use: Swallow the tablet whole with a glass of water. It is best taken with food to reduce the risk of gastrointestinal discomfort.\nConsistency: For optimal results, take HYDROQUIZ 400 at the same time each day or week, as prescribed, to maintain consistent medication levels in your body.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \nBUY NOW\nhttps://www.sterisonline.com/product/hydroquiz-400-134144", "price": 133.0, "discountamount": 39.9, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "BUY", "life", "body", "risk", "food", "400mg", "EMAIL", "glass", "water", "growth", "lesions", "fatigue", "initial", "product", "mobility", "parasite", "response", "Oral Use", "Benefits", "swelling", "same time", "travelers", "HYDROQUIZ", "stiffness", "Management", "four weeks", "joint pain", "one tablet", "information", "skin rashes", "Consistency", "sterisonline", "inflammation", "usual dosage", "Introduction", "sterispharma", "joint damage", "specific case", "long-term use", "CALL/WHATSAPP", "immune system", "Key Ingredient", "specific needs", "lupus patients", "healthier skin", "typical dosage", "red blood cells", "overall quality", "optimal results", "follow-up doses", "Long-Term Safety", "Malaria Treatment", "Malaria Prevention", "chronic conditions", "Hydroxychloroquine", "valuable medication", "skin manifestations", "autoimmune diseases", "Antimalarial Action", "healthcare provider", "lupus erythematosus", "autoimmune reactions", "malaria-endemic area", "versatile medication", "Enhanced Skin Health", "Plasmodium falciparum", "autoimmune conditions", "Administration Dosage", "malaria-endemic regions", "Immunomodulatory Effects", "favorable safety profile", "gastrointestinal discomfort", "Anti-Inflammatory Properties", "consistent medication levels", "rheumatoid arthritis symptoms" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1663, "imageuri": "https://productimages.withfloats.com/actual/6666d14a8c6c791fd3adf5cf.png", "tileimageuri": "https://productimages.withfloats.com/tile/6666d14a8c6c791fd3adf5cf.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-10T10:11:19.106Z", "updatedon": "2024-06-29T10:22:43.511Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/hydroquiz-400-/1663", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "HYDROQUIZ 400 ", "category": "ORTHOLOGYRANG", "tags": [ "HYDROQUIZ 400 mg", "Hydroxychloroquine (400mg)", "", "hydroxychloroquine 400 mg uses in hindi", "", "hydroxychloroquine 200 mg uses", "", "", "hcqs 400 mg side effects", "" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "6666d033a563af1f94f7b647", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "HYDROQUIZ 200 ", "description": "HYDROQUIZ 200 \nHydroxychloroquine (200mg)\nIntroduction\nHYDROQUIZ 200 contains Hydroxychloroquine (200mg), a medication widely used to treat and manage autoimmune conditions such as rheumatoid arthritis and lupus erythematosus. It is also known for its antimalarial properties, making it effective in preventing and treating malaria. Hydroxychloroquine works by modulating the immune system and reducing inflammation, providing relief from symptoms and improving the quality of life for patients.\n\nKey Ingredient and Its Benefits\nHydroxychloroquine (200mg)\nImmunomodulatory Effects: Hydroxychloroquine modulates the immune system, helping to control autoimmune reactions and reduce inflammation. This makes it effective in treating autoimmune conditions like rheumatoid arthritis and lupus.\nAnti-Inflammatory Properties: By reducing inflammation, Hydroxychloroquine helps alleviate symptoms such as joint pain, swelling, and stiffness associated with rheumatoid arthritis.\nAntimalarial Action: Hydroxychloroquine is effective in preventing and treating malaria caused by Plasmodium falciparum. It interferes with the growth of the parasite in red blood cells.\nSkin Health: Hydroxychloroquine is used to treat skin conditions associated with lupus erythematosus, helping to reduce rashes and skin lesions.\nBenefits of HYDROQUIZ 200\nTreatment of Rheumatoid Arthritis: HYDROQUIZ 200 helps manage symptoms of rheumatoid arthritis by reducing inflammation and joint damage, improving mobility and quality of life.\nManagement of Lupus Erythematosus: The immunomodulatory effects of Hydroxychloroquine make it effective in treating lupus, reducing symptoms such as skin rashes, joint pain, and fatigue.\nMalaria Prevention and Treatment: Hydroxychloroquine is effective in preventing and treating malaria, making it a valuable option for travelers to malaria-endemic regions.\nImproved Skin Health: For patients with lupus, HYDROQUIZ 200 helps reduce skin rashes and lesions, promoting healthier skin.\nLong-Term Safety: When used as directed, Hydroxychloroquine has a good safety profile for long-term use, making it suitable for chronic conditions.\nDosage and Administration\nDosage\nRheumatoid Arthritis and Lupus: The typical dosage for autoimmune conditions is one tablet (200mg) taken once or twice daily, as prescribed by a healthcare provider. Dosage may be adjusted based on the patient’s response to treatment and specific needs.\nMalaria Prevention: For malaria prevention, the usual dosage is one tablet (200mg) taken once weekly, starting one to two weeks before entering a malaria-endemic area and continuing for four weeks after leaving the area.\nMalaria Treatment: For treating malaria, the initial dosage and follow-up doses are determined by a healthcare provider based on the specific case.\nAdministration\nOral Use: Swallow the tablet whole with a glass of water. It is best taken with food to reduce the risk of gastrointestinal discomfort.\nConsistency: For optimal results, take HYDROQUIZ 200 at the same time each day or week, as prescribed, to maintain consistent levels of the medication in your body.\nFor further information: \nEMAIL: info@sterispharma.com / contact@sterispharma.com \n CALL/WHATSAPP: 7877551268, 7849827488 \nBUY NOW\nhttps://www.sterisonline.com/product/hydroquiz-200-133903", "price": 110.55, "discountamount": 33.17, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 7, "_keywords": [ "BUY", "life", "body", "risk", "food", "200mg", "EMAIL", "glass", "water", "relief", "growth", "quality", "fatigue", "product", "swelling", "response", "symptoms", "patients", "Benefits", "mobility", "parasite", "Oral Use", "travelers", "HYDROQUIZ", "same time", "stiffness", "medication", "one tablet", "joint pain", "Management", "four weeks", "skin rashes", "information", "Consistency", "Introduction", "usual dosage", "skin lesions", "sterisonline", "inflammation", "joint damage", "sterispharma", "long-term use", "immune system", "CALL/WHATSAPP", "specific case", "initial dosage", "specific needs", "typical dosage", "healthier skin", "Key Ingredient", "red blood cells", "skin conditions", "optimal results", "valuable option", "follow-up doses", "Long-Term Safety", "Malaria Treatment", "consistent levels", "Hydroxychloroquine", "chronic conditions", "Malaria Prevention", "Antimalarial Action", "lupus erythematosus", "good safety profile", "healthcare provider", "malaria-endemic area", "autoimmune reactions", "rheumatoid arthritis", "Improved Skin Health", "autoimmune conditions", "Administration Dosage", "Plasmodium falciparum", "malaria-endemic regions", "antimalarial properties", "Immunomodulatory Effects", "gastrointestinal discomfort", "Anti-Inflammatory Properties" ], "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 1662, "imageuri": "https://productimages.withfloats.com/actual/6666d035117f82c50b03ed70.png", "tileimageuri": "https://productimages.withfloats.com/tile/6666d035117f82c50b03ed70.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2024-06-10T10:06:43.591Z", "updatedon": "2024-06-27T10:07:11.52Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/hydroquiz-200-/1662", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "HYDROQUIZ 200 ", "category": "ORTHOLOGYRANG", "tags": [ "HYDROQUIZ 200 mg", "Hydroxychloroquine (200mg)", "", "hydroxychloroquine 200 mg uses", "", "hydroxychloroquine used for", "", "hydroxychloroquine 200 mg price", "", "hydroxychloroquine side effects" ], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": "", "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68e7a474f3481c1f16d3b038", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Sitagliptin (50mg), Metformin Hydrochloride (500mg) & Glimepiride (2mg)", "description": "Sitagliptin 50mg, Metformin Hydrochloride 500mg & Glimepiride 2mg is a combination oral medication designed for the effective management of type 2 diabetes mellitus. This triple-action formula works synergistically to control blood glucose levels by addressing insulin resistance, enhancing insulin secretion, and regulating post-meal sugar spikes. Ideal for patients who require more than one mechanism to maintain stable blood sugar, this combination is often prescribed when monotherapy or dual therapy is insufficient.\n\nUses\n\nManagement of Type 2 Diabetes Mellitus in adults.\n\nHelps in controlling fasting and postprandial blood glucose levels.\n\nRecommended for patients whose blood sugar is not adequately controlled with a single antidiabetic medicine.\n\nCan be used as part of a comprehensive diabetes management plan, including diet and exercise.\n\nKey Benefits\n\nDual Mechanism Control:\n\nMetformin Hydrochloride reduces hepatic glucose production and improves insulin sensitivity.\n\nGlimepiride stimulates pancreatic beta cells to secrete more insulin.\n\nSitagliptin enhances incretin hormones, leading to better regulation of post-meal glucose levels.\n\nEffective Blood Sugar Management:\nHelps maintain optimal fasting and postprandial glucose levels, reducing the risk of diabetes-related complications.\n\nConvenient Combination Therapy:\nCombines three mechanisms in a single tablet, reducing the pill burden and improving patient compliance.\n\nSupports Overall Health:\nHelps prevent long-term complications such as neuropathy, nephropathy, retinopathy, and cardiovascular risks associated with diabetes.\n\nPossible Side Effects\n\nWhile generally well-tolerated, some patients may experience:\n\nGastrointestinal issues: nausea, vomiting, diarrhea, or abdominal discomfort (mainly from Metformin).\n\nHypoglycemia (low blood sugar): more likely due to Glimepiride; symptoms include dizziness, sweating, or shakiness.\n\nAllergic reactions: rash, itching, or swelling in rare cases.\n\nOther mild effects: headache, fatigue, or minor changes in taste.\n\nNote: Patients should always consult their doctor before starting this combination and report any unusual symptoms immediately.\n\nConclusion\n\nThe Sitagliptin, Metformin Hydrochloride & Glimepiride combination provides a powerful, multi-targeted approach to managing type 2 diabetes. By tackling high blood sugar from different angles, it supports better glucose control, enhances overall quality of life, and reduces the risk of diabetes-related complications. When used alongside proper diet, exercise, and medical guidance, this combination can be a cornerstone in effective diabetes management.", "price": 180.0, "discountamount": 54.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2185, "imageuri": "https://productimages.withfloats.com/actual/68e7a47b040520d37b5e6b34.png", "tileimageuri": "https://productimages.withfloats.com/tile/68e7a47b040520d37b5e6b34.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-09T12:03:00.012Z", "updatedon": "2025-10-09T12:03:00.012Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/sitagliptin-50mg-metformin-hydrochloride-500mg-glimepiride-2mg-/2185", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "ST GLIPTIN GM", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68e63e06f3481c1f16d3ae51", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Tenofovir Alafenamide 25 mg", "description": "TELAVINCE AF 25 is primarily indicated for:\n\nHypertension (High Blood Pressure): Effectively helps in lowering elevated blood pressure.\n\nCardiovascular Risk Reduction: Supports heart health and reduces the risk of heart attack, stroke, and other complications related to high blood pressure.\n\nPatients requiring combination therapy: Ideal for individuals who need more than one antihypertensive agent for optimal blood pressure control.\n\nMechanism of Action:\n\nTELAVINCE AF 25 combines two mechanisms for effective blood pressure management:\n\nTelmisartan: Blocks angiotensin II receptors, preventing blood vessel constriction and thereby reducing blood pressure.\n\n[AF Component, e.g., Amlodipine]: Relaxes blood vessels by inhibiting calcium entry into vascular smooth muscles, improving blood flow and reducing strain on the heart.\n\nThis dual-action combination provides better efficacy than single-drug therapy while maintaining a favorable safety profile.\n\nDosage and Administration:\n\nRecommended Dose: As prescribed by a healthcare professional, typically one tablet daily.\n\nRoute: Oral, with water.\n\nTiming: Can be taken with or without food, preferably at the same time each day.\n\nAdjustment: Dose may be adjusted based on individual response and tolerability.\n\nImportant: Always follow your doctor’s instructions. Do not change the dose or stop medication without medical advice.\n\nKey Benefits of TELAVINCE AF 25:\n\nEffective blood pressure control with dual-action therapy.\n\nReduces the risk of cardiovascular complications associated with hypertension.\n\nConvenient once-daily dosing for better patient adherence.\n\nWell-tolerated with minimal side effects.\n\nSuitable for long-term use under medical supervision.\n\nSafety and Precautions:\n\nInform your doctor if you have kidney disease, liver disease, or heart failure.\n\nPregnant or breastfeeding women should use only if recommended by a physician.\n\nAvoid excessive use of potassium-containing salt substitutes.\n\nRegular monitoring of blood pressure and kidney function is recommended.\n\nDo not combine with other angiotensin receptor blockers (ARBs) unless prescribed.\n\nPossible Side Effects:\n\nWhile generally well-tolerated, some patients may experience:\n\nDizziness or lightheadedness\n\nFatigue or weakness\n\nMild swelling of ankles or feet\n\nNausea or headache\n\nSeek immediate medical attention if you experience:\n\nSevere allergic reactions\n\nSwelling of face, lips, or throat\n\nDifficulty breathing\n\nStorage Instructions:\n\nStore in a cool, dry place away from sunlight.\n\nKeep out of reach of children and pets.\n\nDo not use after the expiry date mentioned on the package.\n\nWhy Choose TELAVINCE AF 25:\n\nDeveloped by Steris Healthcare Pvt. Ltd, a trusted pharmaceutical company.\n\nEnsures quality, safety, and efficacy in every tablet.\n\nDesigned for patient convenience with once-daily dosing.\n\nBacked by clinical research for effective hypertension management.\n\nDisclaimer:\n\nThe information provided here is for educational purposes only. TELAVINCE AF 25 should be used only under medical supervision. Consult your healthcare provider for personalized advice. Side effects may vary from person to person.\n\n", "price": 1566.0, "discountamount": 470.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2184, "imageuri": "https://productimages.withfloats.com/actual/68e63e0d931b4d6a7310ae2a.png", "tileimageuri": "https://productimages.withfloats.com/tile/68e63e0d931b4d6a7310ae2a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-08T10:33:42.289Z", "updatedon": "2025-10-08T10:35:29.464Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tenofovir-alafenamide-25-mg/2184", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Steris Healthcare Pvt. Ltd.", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68e63c17e7475f0f453d4b6e", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Tenofovir (300mg), Emtricitabine (200mg) & Efavirenz (600 mg)", "description": "TELAVINCE EM is primarily indicated for the management of:\n\nHypertension (High Blood Pressure): Helps in reducing elevated blood pressure effectively.\n\nCardiovascular Risk Reduction: Supports heart health and reduces the risk of stroke, heart attack, and related complications.\n\nPatients requiring combination therapy: Suitable for individuals who need more than one antihypertensive for better blood pressure control.\n\nMechanism of Action:\n\nTELAVINCE EM works through a dual mechanism to control blood pressure:\n\nTelmisartan: Blocks angiotensin II receptors, preventing blood vessel constriction and reducing blood pressure.\n\n[EM Component, e.g., Amlodipine]: Relaxes blood vessels by inhibiting calcium entry into vascular smooth muscles, improving blood flow and reducing strain on the heart.\n\nThe combination ensures better efficacy than monotherapy while maintaining a favorable safety profile.\n\nDosage and Administration:\n\nRecommended Dose: As prescribed by a healthcare professional, typically one tablet daily.\n\nRoute: Oral administration with water.\n\nTiming: Can be taken with or without food, preferably at the same time each day.\n\nAdjustment: Dose may be modified based on individual response and tolerability.\n\nImportant: Always follow your doctor’s instructions. Do not alter the dose or stop medication without medical advice.\n\nKey Benefits of TELAVINCE EM:\n\nEffective blood pressure control with dual-action therapy.\n\nReduces risk of cardiovascular events associated with hypertension.\n\nConvenient once-daily dosing improves patient compliance.\n\nWell-tolerated with a low incidence of side effects.\n\nSuitable for long-term use under medical supervision.\n\nSafety and Precautions:\n\nInform your doctor if you have kidney disease, liver disease, or heart failure.\n\nPregnant or breastfeeding women should avoid use unless advised by a physician.\n\nAvoid excessive salt substitutes containing potassium.\n\nRegular blood pressure and kidney function monitoring is recommended.\n\nDo not use in combination with other angiotensin receptor blockers (ARBs) unless prescribed.\n\nPossible Side Effects:\n\nAlthough TELAVINCE EM is generally well-tolerated, some patients may experience:\n\nDizziness or lightheadedness\n\nFatigue or weakness\n\nMild swelling in ankles or feet\n\nNausea or headache\n\nSeek immediate medical attention if you experience severe side effects such as difficulty breathing, swelling of face or throat, or severe allergic reactions.\n\nStorage Instructions:\n\nStore in a cool, dry place away from direct sunlight.\n\nKeep out of reach of children and pets.\n\nDo not use after the expiry date mentioned on the package.\n\nWhy Choose TELAVINCE EM:\n\nDeveloped by Steris Healthcare Pvt. Ltd, a trusted name in pharmaceutical excellence.\n\nEnsures quality, safety, and efficacy in every tablet.\n\nDesigned for optimal patient compliance with convenient dosing.\n\nBacked by clinical research for managing hypertension effectively.\n\nDisclaimer:\n\nThe information provided here is intended for educational purposes only. TELAVINCE EM should be used only under medical supervision. Consult your healthcare provider for personalized advice. Side effects may vary from person to person.", "price": 4715.0, "discountamount": 1415.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2183, "imageuri": "https://productimages.withfloats.com/actual/68e63c1a4302b5c8207e2858.png", "tileimageuri": "https://productimages.withfloats.com/tile/68e63c1a4302b5c8207e2858.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-10-08T10:25:27.075Z", "updatedon": "2025-10-08T10:36:46.57Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/tenofovir-300mg-emtricitabine-200mg-efavirenz-600-mg-/2183", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Steris Healthcare Pvt. Ltd.", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d51d9a26579f4bc195771a", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Glimepiride IP1 mg, Voglibose IP 0.2 MG & Metformin Hydrochloride IP 500 mg ", "description": "GLIMITERIS MV1 0.2 is an advanced fixed-dose combination (FDC) medication designed for adults with Type 2 Diabetes Mellitus (T2DM) who require more than lifestyle modifications or single/dual therapy to maintain optimal blood sugar levels. This innovative formulation brings together the power of three well-established antidiabetic agents—Glimepiride (1 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg)—to provide comprehensive glycemic control.\n\nIt is particularly effective for patients struggling with postprandial hyperglycemia, fasting glucose regulation, and HbA1c reduction, making it a preferred choice in cases of poorly controlled diabetes.\n\n \n\nMechanism of Action\nThe therapeutic benefit of GLIMITERIS MV1 0.2 comes from the unique synergy of its three components, each targeting different aspects of glucose metabolism:\n\n1. Glimepiride (1 mg) – Sulfonylurea\nStimulates insulin secretion by activating pancreatic beta cells.\n\nProvides a long-lasting effect with comparatively lower hypoglycemia risk than older sulfonylureas.\n\nHelps reduce both fasting and postprandial glucose levels.\n\n2. Voglibose (0.2 mg) – Alpha-Glucosidase Inhibitor\nDelays the breakdown and absorption of carbohydrates in the intestine.\n\nMinimizes post-meal glucose spikes (PPBG).\n\nActs locally in the gut and has minimal systemic absorption, which reduces systemic side effects.\n\n3. Metformin Hydrochloride SR (500 mg) – Biguanide\nDecreases hepatic glucose production (gluconeogenesis).\n\nImproves peripheral insulin sensitivity, enhancing glucose uptake in muscles.\n\nDoes not cause hypoglycemia on its own.\n\nThe sustained-release (SR) formulation ensures extended control and reduces gastrointestinal side effects.\n\n \n\nIndications\nGLIMITERIS MV1 0.2 is indicated for:\n\nAdults with Type 2 Diabetes Mellitus.\n\nPatients inadequately controlled with monotherapy or dual therapy.\n\nManagement of fasting and postprandial hyperglycemia.\n\nLong-term HbA1c reduction as part of a comprehensive diabetes care plan.\n\n \n\nKey Benefits\n✅ Comprehensive Blood Sugar Control – Acts on fasting, post-meal, and long-term HbA1c levels.\n✅ Postprandial Spike Management – Voglibose effectively controls carbohydrate-induced sugar surges.\n✅ Reduced Pill Burden – Combines three medicines into a single tablet.\n✅ Lower Hypoglycemia Risk – Metformin and Voglibose balance out Glimepiride’s insulin-secreting effect.\n✅ Weight Management Support – Metformin may promote modest weight loss or prevent weight gain.\n✅ Improved Tolerability – SR formulation of Metformin enhances gastrointestinal comfort.\n\n \n\nDosage and Administration\nRecommended dose: One tablet once or twice daily with meals, or as directed by the physician.\n\nAdministration tips:\n\nTake with the first bite of a main meal to maximize Voglibose’s effect.\n\nSwallow whole with water; do not crush or chew the SR tablet.\n\nDose adjustments: Based on blood sugar monitoring, clinical response, and renal/hepatic function.\n\n \n\nContraindications\nGLIMITERIS MV1 0.2 is not suitable for patients with:\n\nType 1 diabetes or diabetic ketoacidosis.\n\nSevere renal impairment (eGFR <30 mL/min/1.73 m²).\n\nHepatic dysfunction.\n\nSevere gastrointestinal diseases.\n\nHistory of lactic acidosis.\n\nHypersensitivity to Glimepiride, Voglibose, or Metformin.\n\nPregnancy and lactation (unless strictly advised by a physician).\n\n \n\nWarnings and Precautions\nHypoglycemia: Risk is higher when combined with other antidiabetics or with missed meals.\n\nLactic Acidosis: A rare but life-threatening effect of Metformin—renal function monitoring is essential.\n\nGI Side Effects: Voglibose and Metformin may cause bloating, flatulence, or diarrhea (usually temporary).\n\nVitamin B12 Monitoring: Long-term Metformin use may reduce B12 absorption.\n\nLiver and Kidney Function: Regular monitoring is recommended for safe long-term use.\n\n \n\nAdverse Effects\nCommon:\nGlimepiride: Mild hypoglycemia, dizziness, slight weight gain.\n\nVoglibose: Gas, abdominal discomfort, mild diarrhea.\n\nMetformin SR: Nausea, bloating, metallic taste, loose stools.\n\nRare but Serious:\nLactic acidosis (from Metformin).\n\nSevere hypoglycemia (especially if meals are skipped).\n\nAllergic reactions such as rash, itching, or swelling.\n\nElevated liver enzymes.\n\nSeek medical attention if symptoms such as rapid breathing, confusion, severe fatigue, or muscle pain occur.\n\n \n\nDrug Interactions\nIncreased hypoglycemia risk: With insulin, beta-blockers, and sulfonylureas.\n\nReduced Metformin efficacy: With corticosteroids, estrogens, and diuretics.\n\nLactic acidosis risk: Higher with alcohol or iodinated contrast agents. ", "price": 263.0, "discountamount": 80.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2182, "imageuri": "https://productimages.withfloats.com/actual/68d51d9cdf1a4ca2c252370a.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d51d9cdf1a4ca2c252370a.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:46:50.098Z", "updatedon": "2025-10-02T11:20:20.402Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/glimepiride-ip1-mg-voglibose-ip-0-2-mg-metformin-hydrochloride-ip-500-mg-/2182", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "GLIMITERIS MV1 0.2", "category": "", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68d518ce6b4e65282a1dc798", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "Formoterol Fumarate Dihydrate Ip 6 mcg & Budesonide IP 400 mcg", "description": "BUDESHINE F 400 CAP - This is a combination inhalation therapy used in the management of asthma and Chronic Obstructive Pulmonary Disease (COPD).\n\n \nMechanism of Action:\n\nFormoterol Fumarate: A long-acting β2-adrenergic agonist (LABA) that relaxes airway smooth muscles, providing rapid and sustained bronchodilation.\n\nBudesonide: An inhaled corticosteroid (ICS) that reduces airway inflammation, swelling, and mucus production.\n\nTogether, they offer dual action—quick relief of bronchospasm and long-term control of airway inflammation.\n\n \n\nIndications:\n\nAsthma (for patients not controlled adequately with inhaled corticosteroids alone).\n\nChronic Obstructive Pulmonary Disease (COPD) with reversible airway obstruction.\n\nPrevention of asthma attacks and reduction of COPD exacerbations.\n\n \n\nKey Benefits:\n\nProvides fast and sustained relief from breathing difficulty.\n\nControls both inflammation and bronchospasm.\n\nReduces the frequency and severity of asthma/COPD flare-ups.\n\nImproves overall lung function and quality of life.\n\n \nDosage and Administration:\n\nAdministered via inhalation as directed by a physician.\n\nDose depends on the severity of disease and patient response.\n\nRegular use is required for effective control—not for acute asthma attacks.\n(Exact dosing schedule to be prescribed by the doctor.)", "price": 238.0, "discountamount": 72.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2181, "imageuri": "https://productimages.withfloats.com/actual/68d518d1c1505f341d018bb1.png", "tileimageuri": "https://productimages.withfloats.com/tile/68d518d1c1505f341d018bb1.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-25T10:26:22.554Z", "updatedon": "2025-09-25T10:26:22.554Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/formoterol-fumarate-dihydrate-ip-6-mcg-budesonide-ip-400-mcg/2181", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "BUDESHINE F 400 CAP", "category": "ASTHMA RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68c29ba02244c906e7790e2b", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "TELAVINCE 300", "description": "TELAVINCE 300 is a high-quality antiviral medication containing Tenofovir Disoproxil Fumarate 300 mg, specifically formulated for the effective management of HIV-1 infection and chronic Hepatitis B in adults and adolescents. Manufactured under strict pharmaceutical standards, TELAVINCE 300 offers consistent, potent, and clinically proven antiviral action, helping to suppress viral replication and improve immune function.\n\nTenofovir Disoproxil Fumarate is a nucleotide reverse transcriptase inhibitor (NtRTI). It works by interfering with the enzyme reverse transcriptase, which is essential for viral replication in HIV and Hepatitis B viruses. By inhibiting this enzyme, TELAVINCE 300 reduces the amount of virus in the body, helping to prevent further immune system damage and liver complications.\n\n \nKey Indications:\n \n\nTELAVINCE 300 is indicated for:\n\nHIV-1 Infection: In combination with other antiretroviral agents for the treatment of HIV-1 in adults and adolescents (aged 12 years and older, weighing at least 35 kg).\n\nChronic Hepatitis B: For the treatment of chronic hepatitis B virus infection in adults and adolescents with compensated liver disease and evidence of active viral replication.\n\n \nMechanism of Action:\n \nTenofovir Disoproxil Fumarate is a prodrug of tenofovir, which, once absorbed and metabolized in the body, is converted into tenofovir diphosphate, the active form. Tenofovir diphosphate acts as a competitive inhibitor of reverse transcriptase, incorporating itself into the viral DNA chain and causing premature chain termination. This process disrupts the life cycle of the virus, significantly reducing its ability to multiply and spread.\n\n \nDosage and Administration:\n \n\nRecommended Dose for Adults and Adolescents (≥12 years, ≥35 kg): One tablet (300 mg) once daily, preferably with food.\n\nFor HIV Treatment: Administer in combination with other antiretroviral medications as per the treatment regimen.\n\nFor Chronic Hepatitis B: Monotherapy or as part of combination therapy, depending on patient condition and physician's assessment.\n\nDosage adjustments may be required in patients with renal impairment. Close monitoring is recommended for patients with existing kidney disease.\n\n \nKey Benefits of TELAVINCE 300:\n \n\nPotent Antiviral Action: Rapid and sustained suppression of HIV and HBV replication.\nOnce-Daily Dosing: Improves patient compliance and treatment adherence.\n\nBacked by Clinical Research: Proven efficacy in managing viral load and improving immune markers (CD4 count).\n\nTrusted Quality: Manufactured under GMP-certified facilities with stringent quality control processes.\n\nPart of First-Line Therapy: Recommended in various national and international treatment guidelines for HIV and Hepatitis B.\n\n \nSafety and Precautions:\n \n\nRenal Monitoring: Tenofovir may affect kidney function. Routine renal function tests are recommended before and during treatment.\n\nBone Mineral Density: Long-term use may reduce bone mineral density. Consider monitoring in patients at risk of osteopenia or osteoporosis.\n\nHepatic Flare: Discontinuation of therapy in hepatitis B patients may result in severe acute exacerbations. Liver function should be closely monitored post-treatment.\n\nLactic Acidosis and Hepatomegaly: Rare but serious side effects. Patients presenting symptoms such as abdominal pain, fatigue, or difficulty breathing should seek immediate medical attention.\n\n \n\nPossible Side Effects:\n \n\nMost patients tolerate TELAVINCE 300 well. However, some may experience:\n\nNausea\n\nDiarrhea\n\nHeadache\n\nFatigue\n\nRash\n\nDizziness\n\nDecreased bone mineral density\n\nRenal impairment (in rare cases)\n\nIf any side effects persist or worsen, consult a healthcare professional immediately.\n\n \nStorage Instructions:\n \n\nStore in a cool, dry place below 30°C.\n\nProtect from light and moisture.\n\nKeep out of reach of children.\n\n \n\nWhy Choose TELAVINCE 300?\n \n\nTELAVINCE 300 offers a dependable, clinically validated solution for the long-term management of HIV and Hepatitis B. With its once-daily dosing and proven effectiveness, TELAVINCE 300 is an ideal choice for patients and healthcare providers looking for quality, safety, and therapeutic reliability. It is manufactured by a trusted name in healthcare, ensuring every tablet meets global pharmaceutical standards.\n\n \nDisclaimer:\n \n\nThis product description is for informational purposes only and is not a substitute for professional medical advice. Always consult your doctor or healthcare provider before starting any medication.", "price": 1480.0, "discountamount": 444.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2179, "imageuri": "https://productimages.withfloats.com/actual/68c29ba3794abb27ab248d73.png", "tileimageuri": "https://productimages.withfloats.com/tile/68c29ba3794abb27ab248d73.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-11T09:51:28.508Z", "updatedon": "2025-09-11T09:51:28.508Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/telavince-300/2179", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "Tenofovir Disoproxil Fumarate Tablets ip 300 mg", "category": "GENERAL RANGE", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false }, { "_id": "68beb577cb617ef27c577d94", "fptag": "STERISHEALTHCARE", "merchantname": null, "customwidgets": null, "externalsourceid": null, "name": "CEPHODOXIAA 50 DS", "description": "CEPHODOXIAA 50 DS is an oral suspension containing Cefpodoxime Proxetil, a third-generation cephalosporin antibiotic. It is widely prescribed for the treatment of bacterial infections in adults and children, including infants and babies.Oral suspension form is particularly useful for children and patients who have difficulty swallowing tablets, ensuring accurate dosing and better compliance.\nComposition\nActive Ingredient: Cefpodoxime Proxetil 50 mg per 5 ml suspension\nBrand Name: CEPHODOXIAA 50 DS\nForm: Oral Suspension\nDrug Class: Cephalosporin Antibiotic\nExcipients: Flavors, sweeteners, stabilizers for palatability and suspension stability\nCefpodoxime Proxetil Oral Suspension IP Uses\nCEPHODOXIAA 50 DS is prescribed for a wide variety of bacterial infections:\nRespiratory Tract Infections\nTonsillitis, Pharyngitis\nBronchitis and Pneumonia\nEar, Nose & Throat (ENT) Infections\nAcute Sinusitis\nOtitis Media (middle ear infection)\nUrinary Tract Infections (UTIs)\nCystitis and kidney infections\nSkin & Soft Tissue Infections\nImpetigo, Cellulitis\nInfected wounds and abscesses\nOther Indications\nGonorrhea (in selected cases)\nPediatric bacterial infections where oral dosing is preferred\nFor babies and children: The oral suspension allows precise weight-based dosing, making it safe and convenient for pediatric infections.\nHow Cefpodoxime Proxetil Oral Suspension Works\nCefpodoxime Proxetil is a beta-lactam antibiotic that:\nInhibits bacterial cell wall synthesis\nWeakens bacterial cells, causing cell death\nEffective against both Gram-positive and Gram-negative bacteria\nThis mechanism helps control infections and prevents their spread.\nDosage & Administration \nInfants & Children: Dose is based on body weight and prescribed by a pediatrician.\nCommonly 5–10 mg/kg/day, divided into 2 doses daily.\nAdults: Typically 100–200 mg every 12 hours, depending on infection severity.\nAdministration Tips:\nShake the bottle well before use.\nUse the measuring cup or spoon provided for accurate dosing.\nCan be taken with or without food, but giving after meals may reduce stomach upset.\nComplete the full course even if symptoms improve.\nBenefits of Cefpodoxime Proxetil Oral Suspension\nEasy to administer for children and babies\nBroad-spectrum coverage for respiratory, urinary, and skin infections\nHelps in rapid infection control\nSafe and effective with minimal side effects when taken as prescribed\nSuspension form allows accurate weight-based dosing\nSide Effects of Cefpodoxime Proxetil Oral Suspension\nMild side effects may include:\nDiarrhea or loose stools\nNausea or vomiting\nStomach pain\nHeadache or dizziness\nSkin rash or itching\nSerious side effects (rare):\nSevere allergic reaction (swelling, rash, difficulty breathing)\nSevere diarrhea indicating Clostridium difficile infection\nLiver enzyme elevation\nSeek medical attention if any severe or persistent side effects occur.\nPrecautions & Warnings\nAvoid if allergic to cephalosporins, penicillin, or other beta-lactam antibiotics\nUse cautiously in patients with kidney or liver disease\nNot effective against viral infections like flu or common cold\nPregnant or breastfeeding women should consult a doctor before use\nAlways complete the full prescribed course to prevent antibiotic resistance\nDrug Interactions\nAntacids containing magnesium or aluminum may reduce absorption\nProton pump inhibitors (PPIs) like omeprazole\nBlood thinners (e.g., warfarin – monitor for increased bleeding risk)\nOther antibiotics may interact and alter effectiveness\nConclusion\nCEPHODOXIAA 50 DS (Cefpodoxime Proxetil Oral Suspension IP) is a safe and effective solution for treating bacterial infections in adults, children, and babies.", "price": 100.0, "discountamount": 30.0, "currencycode": "INR", "priority": 1000000, "isfreeshipmentavailable": false, "shipmentduration": 1, "_keywords": null, "isarchived": false, "isavailable": true, "applicationid": null, "productindex": 2178, "imageuri": "https://productimages.withfloats.com/actual/68beb57bed36b14275f756c2.png", "tileimageuri": "https://productimages.withfloats.com/tile/68beb57bed36b14275f756c2.png", "images": null, "totalqueries": 0, "gpid": null, "groupproductid": null, "createdon": "2025-09-08T10:52:39.162Z", "updatedon": "2025-09-08T10:52:39.162Z", "buyonlinelink": null, "producturl": "http://WWW.STERISINDIA.COM/products/cephodoxiaa-50-ds/2178", "availableunits": -1.0, "iscodavailable": false, "isprepaidonlineavailable": false, "maxcodorders": 0, "maxprepaidonlineorders": 0, "uniquepaymenturl": null, "brandname": "cefpodoxime proxetil oral suspension ip 50 mg", "category": "Pediatric", "tags": [], "variants": false, "keyspecification": null, "otherspecifications": null, "pickupaddressreferenceid": null, "paymenttype": "UniquePaymentUrl", "producttype": "products", "hsncode": null, "gstslab": 0.0, "isnotforsale": false } ], "hasmoreitems": false, "isapirequest": false, "totalresults": 27, "query": null, "floatingpoint": null }